Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Mouse CD32/CD16 (Fcγ R III/II, Ly-17) In Vivo GOLD; Clone 2.4G2; Isotype: Rat IgG2b
SDP

Supplier:  Leinco Technologies Inc C3811.0 MG

Encompass_Preferred

Specificity: Clone 2.4G2 recognizes the FcγIII and FcγII receptors. Antigen Distribution: These receptors are present on B cells, monocyte/macrophages, NK cells, neutrophils, mast cells and dendritic cells. Background: The FcγIII/II receptors are 40-60 kD and part of the Ig superfamily. They bind antibody-antigen immune complexes and mediate adaptive immune responses. Applications: (WB, B) Clone 2.4G2 antibody is used in flow cytometry staining experiments to prevent non-specific binding of IgG to the FcγIII and FcγII, and possibly FcγI, receptors prior to staining with antigen-specific primary antibodies. Fab fragments of 2.4G2 have been used to block Fc receptors In vivo. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6123


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.